ArticleOncology letters2025

Immunotherapy beyond progression following first‑line chemotherapy plus immunotherapy in advanced non‑small cell lung cancer: A retrospective study.

Xinyue Gu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.